Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1596687

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1596687

Spirulina Market by Type (Arthrospira Maxima, Arthrospira Platensis), Drug Formulation (Granule & Gelling Agent, Liquid, Powder), Application - Global Forecast 2025-2030

PUBLISHED:
PAGES: 186 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Spirulina Market was valued at USD 389.98 million in 2023, expected to reach USD 419.91 million in 2024, and is projected to grow at a CAGR of 7.77%, to USD 658.49 million by 2030.

Spirulina, a cyanobacterium consumed for its nutritional benefits, has gained attention in the health and wellness sector, promising ample opportunities across its application spectrum. The scope of spirulina is expansive, defined by its use in dietary supplements, pharmaceuticals, food and beverages, animal feed, and cosmetics, owing to its rich protein content, vitamins, and antioxidant properties. The necessity of spirulina emerges from the increasing consumer inclination toward plant-based and sustainable nutritional sources, aiming to tackle malnutrition and dietary deficiencies globally. Its application in fortifying food products, bolstering immune function supplements, and acting as a natural colorant in food and cosmetics outlines a broad end-use scope.

KEY MARKET STATISTICS
Base Year [2023] USD 389.98 million
Estimated Year [2024] USD 419.91 million
Forecast Year [2030] USD 658.49 million
CAGR (%) 7.77%

Market dynamics are significantly influenced by health trends and growing veganism, which presents lucrative potential opportunities, particularly in the dietary supplement and cosmetics sectors. Moreover, innovations in cultivation processes, such as the use of closed-system photobioreactors, present opportunities for increased production efficiency and quality enhancement. However, challenges such as high production costs, contamination risk during cultivation, and limited awareness in developing regions hinder market growth. Additionally, consumer perception linking microalgae to aquatic toxins poses a barrier. To capitalize on growth opportunities, stakeholders are encouraged to invest in awareness campaigns and develop cost-effective cultivation technologies.

Innovation opportunities lie in creating spirulina-based functional and fortified food products, expanding its use in pet and animal nutrition, and exploring biofuel production attributes. Moreover, research into enhancing the digestibility and taste of spirulina would broaden its acceptability. The market is characterized by fragmented competition but shows immense potential owing to its alignment with sustainable and health-centric consumer trends. Companies engaging in strategic partnerships for research and development and focusing on establishing sustainable supply chains will likely emerge as leaders in this dynamically evolving sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spirulina Market

The Spirulina Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Awareness of natural health benefits of spirulina superfood
    • Importance of Spirulina in cancer treatment
    • High demand for cyanobacteria for weight reduction and personal care
  • Market Restraints
    • High cost of spirulina
  • Market Opportunities
    • Government initiatives for increasing the production of spirulina
    • Introduction of new varieties of natural food colors produced from spirulina
  • Market Challenges
    • Risk of side effects of overconsumption of spirulina

Porter's Five Forces: A Strategic Tool for Navigating the Spirulina Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spirulina Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spirulina Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spirulina Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spirulina Market

A detailed market share analysis in the Spirulina Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spirulina Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spirulina Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spirulina Market

A strategic analysis of the Spirulina Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spirulina Market, highlighting leading vendors and their innovative profiles. These include Algenol Biofuels Inc., Australian Spirulina, Cabassi & Giuriati SpA, Chr. Hansen Holding A/S, DDW The Color House, DIC Corporation, Dongtai City Spirulina Bio-engineering Co., Ltd, DOHLER GmbH, Earthrise Nutritionals, LLC, Fuqing King Dnarmsa Spirulina Co. Ltd, GNC Holdings, Inc., GNT Holding B.V., Inner Mongolia Rejuve Biotech Co. Ltd., Naturex S.A, and Now Health Group Inc..

Market Segmentation & Coverage

This research report categorizes the Spirulina Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Arthrospira Maxima and Arthrospira Platensis.
  • Based on Drug Formulation, market is studied across Granule & Gelling Agent, Liquid, Powder, and Tablet & Capsule.
  • Based on Application, market is studied across Animal Feed, Cosmetics, Food & Beverages, and Nutraceuticals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-030EC642E04D

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Awareness of natural health benefits of spirulina superfood
      • 5.1.1.2. Importance of Spirulina in cancer treatment
      • 5.1.1.3. High demand for cyanobacteria for weight reduction and personal care
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of spirulina
    • 5.1.3. Opportunities
      • 5.1.3.1. Government initiatives for increasing the production of spirulina
      • 5.1.3.2. Introduction of new varieties of natural food colors produced from spirulina
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of side effects of overconsumption of spirulina
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Spirulina Market, by Type

  • 6.1. Introduction
  • 6.2. Arthrospira Maxima
  • 6.3. Arthrospira Platensis

7. Spirulina Market, by Drug Formulation

  • 7.1. Introduction
  • 7.2. Granule & Gelling Agent
  • 7.3. Liquid
  • 7.4. Powder
  • 7.5. Tablet & Capsule

8. Spirulina Market, by Application

  • 8.1. Introduction
  • 8.2. Animal Feed
  • 8.3. Cosmetics
  • 8.4. Food & Beverages
  • 8.5. Nutraceuticals

9. Americas Spirulina Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Spirulina Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Spirulina Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Algenol Biofuels Inc.
  • 2. Australian Spirulina
  • 3. Cabassi & Giuriati SpA
  • 4. Chr. Hansen Holding A/S
  • 5. DDW The Color House
  • 6. DIC Corporation
  • 7. Dongtai City Spirulina Bio-engineering Co., Ltd
  • 8. DOHLER GmbH
  • 9. Earthrise Nutritionals, LLC
  • 10. Fuqing King Dnarmsa Spirulina Co. Ltd
  • 11. GNC Holdings, Inc.
  • 12. GNT Holding B.V.
  • 13. Inner Mongolia Rejuve Biotech Co. Ltd.
  • 14. Naturex S.A
  • 15. Now Health Group Inc.
Product Code: MRR-030EC642E04D

LIST OF FIGURES

  • FIGURE 1. SPIRULINA MARKET RESEARCH PROCESS
  • FIGURE 2. SPIRULINA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SPIRULINA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SPIRULINA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SPIRULINA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SPIRULINA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SPIRULINA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SPIRULINA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPIRULINA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPIRULINA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPIRULINA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPIRULINA MARKET DYNAMICS
  • TABLE 7. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA MAXIMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA PLATENSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPIRULINA MARKET SIZE, BY GRANULE & GELLING AGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPIRULINA MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPIRULINA MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPIRULINA MARKET SIZE, BY TABLET & CAPSULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SPIRULINA MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SPIRULINA MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SPIRULINA MARKET SIZE, BY FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SPIRULINA MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES SPIRULINA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. SPIRULINA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. SPIRULINA MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!